There is a point that has not been discussed, and it gives me some pleasure. I think the main instigator is the pharmaceutical companies, Pfizer, Glaxo and Pharmacia, not the Tobacco companies!
You're right Bshalaby, it has always been the giant pharmaceuticals that have been trying to squash and kill ecigs. Because ecigs totally threaten their bottom line - profits - as ecigs are so much more effective than the woefully ineffective and hugely expensive Pharma nicotine products, and are much more enjoyable to use as well. And as Vocalek posted, the huge so-called "health" groups that receive millions in funds from the pharmaceuticals have been their front men in that struggle all along.
This ruling turns it upside down for them, it means that ALL nicotine products are tobacco products and not subject to FDA oversight as drugs. It shoots a 3 billion dollar market, which everybody will try to enter, a market they spent 20 years developing, and financing every anti smoking group from the WHO to ASH.
I think this is a great part of the reason for the panicky activity going on right now.
An aspect that worries me a little, is the controversy over nicotine products and Tobacco and it might give probable cause for another supreme court hearing, a la "Brown and Williamson" to decide the second part of the story. Are all Nicotine products Tobacco Products or are they Drugs?
Can anyone in the know answer that question?
However, in this you are wrong. Neither the court ruling nor the tobacco legislation changes
anything with respect to nicotine-based pharma cessation products. The definition of "tobacco product" in the statute, in relevant part, is as follows:
(rr) (1) The term tobacco product means any product
made or derived from tobacco that is intended for human
consumption, including any component, part, or
accessory of a tobacco product . . .
(2) The term tobacco product does not mean an article
that is a drug under [the FDCAs drug provision], a
device under [the FDCAs device provision], or a
combination product described in [the FDCAs
combination product provision].
21 U.S.C. § 321(rr).
As you can see, section one of the statute is what makes ecigs a "tobacco product". But section two is what keeps pharma nicotine products in the same category - drug products - that they have always been in. As the Court of Appeals decision also says: "The Tobacco Act itself states that it does not affect, expand, or limit the FDAs jurisdiction to regulate products under the drug/device provisions of the FDCA, 21 U.S.C. § 387a(c)(1)."
So long as a nicotine product is developed, approved, and marketed specifically with the intended use of treating nicotine addiction and/or smoking cessation, it can and will be regulated by the FDA under the FDCA as a drug product. And that propostion
includes any given ecig brand that wants to market itself specifically as a cessation device. And so said the Court of Appeals decision as well. But ecigs that are marketed
solely as a smoking alternative, or as tobacco products are traditionally marketed, solely for recreational use, they are
only subject to regulation under the tobacco act (well, so long as the Court of Appeals decision is not overturned, which I doubt will happen).